These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30704245)

  • 1. A summary of the EAS consensus concerning the causal relationship between low-density lipoproteins and atherosclerotic cardiovascular diseases, prepared by the Board of the Czech Society for Atherosclerosis.
    Soška V; Karásek D; Bláha V; Cífková R; Freiberger T; Kraml P; Piťha J; Rosolová H; Štulc T; Urbanová Z; Vrablík M
    Vnitr Lek; 2019; 64(12):1124-1128. PubMed ID: 30704245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Critical Review of the Consensus Statement from the European Atherosclerosis Society Consensus Panel 2017.
    Okuyama H; Hamazaki T; Hama R; Ogushi Y; Kobayashi T; Ohara N; Uchino H
    Pharmacology; 2018; 101(3-4):184-218. PubMed ID: 29353277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel.
    Ference BA; Ginsberg HN; Graham I; Ray KK; Packard CJ; Bruckert E; Hegele RA; Krauss RM; Raal FJ; Schunkert H; Watts GF; Borén J; Fazio S; Horton JD; Masana L; Nicholls SJ; Nordestgaard BG; van de Sluis B; Taskinen MR; Tokgözoglu L; Landmesser U; Laufs U; Wiklund O; Stock JK; Chapman MJ; Catapano AL
    Eur Heart J; 2017 Aug; 38(32):2459-2472. PubMed ID: 28444290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherosclerotic risk factors in cardiovascular disease.
    LaRosa JC
    J Reprod Med; 1986 Sep; 31(9 Suppl):906-12. PubMed ID: 3772910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Front line of oxidized lipoproteins: role of oxidized lipoproteins in atherogenesis and cardiovascular disease risk].
    Yoshida H
    Rinsho Byori; 2010 Jun; 58(6):622-30. PubMed ID: 20662275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Triglycerides and Atherosclerotic Cardiovascular Disease: Insights from Clinical and Genetic Studies.
    Tada H; Nohara A; Kawashiri MA
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.
    Tani S; Matsumoto M; Nagao K; Hirayama A
    J Cardiol; 2014 Jan; 63(1):60-8. PubMed ID: 24016623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remnant lipoproteins and atherosclerotic cardiovascular disease.
    Tada H; Nohara A; Inazu A; Mabuchi H; Kawashiri MA
    Clin Chim Acta; 2019 Mar; 490():1-5. PubMed ID: 30553862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary fat quality, plasma atherogenic lipoproteins, and atherosclerotic cardiovascular disease: An overview of the rationale for dietary recommendations for fat intake.
    Christensen JJ; Arnesen EK; Rundblad A; Telle-Hansen VH; Narverud I; Blomhoff R; Bogsrud MP; Retterstøl K; Ulven SM; Holven KB
    Atherosclerosis; 2024 Feb; 389():117433. PubMed ID: 38219649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment.
    Varbo A; Benn M; Nordestgaard BG
    Pharmacol Ther; 2014 Mar; 141(3):358-67. PubMed ID: 24287311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoalbuminemia increases lysophosphatidylcholine in low-density lipoprotein of normocholesterolemic subjects.
    Vuong TD; Stroes ES; Willekes-Koolschijn N; Rabelink TJ; Koomans HA; Joles JA
    Kidney Int; 1999 Mar; 55(3):1005-10. PubMed ID: 10027937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardization of laboratory lipid profile assessment: A call for action with a special focus on the 2016 ESC/EAS dyslipidemia guidelines - Executive summary: A consensus endorsed by the Cardiovascular Risk and Prevention Group of the Portuguese Internal Medicine Society, the Portuguese Atherosclerosis Society, the Portuguese Society of Cardiology, the Portuguese Society of Laboratory Medicine, and the Portuguese Association of Clinical Chemistry.
    da Silva PM; Sequeira Duarte J; von Hafe P; Gil V; Nunes de Oliveira J; de Sousa G
    Rev Port Cardiol (Engl Ed); 2018 Apr; 37(4):279-283. PubMed ID: 29685846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified lipoproteins as biomarkers of cardiovascular risk in diabetes mellitus.
    Sánchez-Quesada JL; Pérez A
    Endocrinol Nutr; 2013 Nov; 60(9):518-28. PubMed ID: 23545115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causal Effect of Lipids and Lipoproteins on Atherosclerosis: Lessons from Genomic Studies.
    Ference BA
    Cardiol Clin; 2018 May; 36(2):203-211. PubMed ID: 29609749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Entire Peroxidation Reaction System of Myeloperoxidase Correlates with Progressive Low-Density Lipoprotein Modifications via Reactive Aldehydes in Atherosclerotic Patients with Hypertension.
    Liu Q; Liu Y; Shi J; Gao M; Liu Y; Cong Y; Li Y; Wang Y; Yu M; Lu Y; Wang D; Chen S; Zheng Y; Cheng Y
    Cell Physiol Biochem; 2018; 50(4):1245-1254. PubMed ID: 30355911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and Cellular Mechanisms of Electronegative Lipoproteins in Cardiovascular Diseases.
    Ke LY; Law SH; Mishra VK; Parveen F; Chan HC; Lu YH; Chu CS
    Biomedicines; 2020 Nov; 8(12):. PubMed ID: 33260304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis.
    Staprans I; Pan XM; Rapp JH; Feingold KR
    Mol Nutr Food Res; 2005 Nov; 49(11):1075-82. PubMed ID: 16270280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The common position of the Czech professional associations on the consensus of the European Atherosclerosis Society and the European Federation of Clinical Chemistry and Laboratory Medicine regarding investigation on blood lipids and interpretation of their levels].
    Soška V; Franeková J; Friedecký B; Jabor A; Kraml P; Rosolová H; Vrablík M
    Vnitr Lek; 2016; 62(12):1034-1040. PubMed ID: 28139134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.